Chris Degnan Galera Therapeutics, Inc. (GRTX) insider trading activity

GRTX Quotes by TradingView

Chris Degnan is Chief Financial Officer of Galera Therapeutics, Inc.. Currently has a direct ownership of 10,000 shares of GRTX, which is worth approximately $300. The most recent transaction as insider was on Mar 13, 2023, when has been sold 10,000 shares (Common Stock) at a price of $1.96 per share, resulting in proceeds of $19,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
0% 3M change
0% 12M change
Total Value Held $300

Chris Degnan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 13 2023
BUY
Open market or private purchase
$19,600 $1.96 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

URGN
UroGen Pharma Ltd. Healthcare
Chief Financial Officer
CD

Chris Degnan

Chief Financial Officer
Malvern, PA

Track Institutional and Insider Activities on GRTX

Follow Galera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRTX shares.

Notify only if

Insider Trading

Get notified when an Galera Therapeutics, Inc. insider buys or sells GRTX shares.

Notify only if

News

Receive news related to Galera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GRTX